Geriatrics News

Among individuals with Alzheimer’s disease with agitation, citalopram was more likely to benefit those with moderate agitation and lower levels of cognitive impairment, whereas those with more severe agitation and greater cognitive impairment were at higher risk for adverse responses.

PsychoGenics Inc. and the Alzheimer’s Drug Discovery Foundation recently announced a new partnership that will enable Alzheimer’s Drug Discovery Foundation grantees access to validated Alzheimer’s disease animal models and experimental services from PsychoGenics.

Recent findings suggest that Lewy body dementia pathology and cerebrovascular disease are significant modifiers of psychosis in Alzheimer’s disease.

As the year comes to a close, Healio.com/Psychiatry revisited our most popular psychiatry coverage of 2015.

As 2015 comes to a close, Healio.com/Psychiatry looked back at the most popular research on Alzheimer’s disease and dementia within the past year.

Anxiety symptoms were associated with an increased risk for dementia, according to recent findings.

Higher perceived stress was associated with a 30% higher risk for incident amnestic mild cognitive impairment among older adults, according to recent findings.

Recent findings show moderate alcohol consumption, defined as two to three units per day, was associated with lower mortality among adults with mild Alzheimer’s disease.

Banner Alzheimer’s Institute recently announced the launch of GeneMatch, a program that identifies individuals interested in volunteering for Alzheimer’s research studies, partly based on their APOE genetic information.

Longitudinal analysis of dementia-free, older adults indicated those with more negative age stereotypes had more significant brain changes related to Alzheimer’s disease, compared with those with positive age stereotypes.